Civil Litigation
Jun. 4, 2018
Judge denies class certification in Theranos investor case
Investors suing blood testing company Theranos Inc. lost some leverage when a magistrate judge in San Jose denied a motion to certify their class action.
Investors suing blood testing company Theranos Inc. lost some leverage when a magistrate judge in San Jose denied a motion to certify their class action.
The investors will have to split up and bring individual suits against the company instead.
The plaintiffs claim that Theranos misled investors with junk science and false statements as the company’s business model collapsed.
$95
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In